Adam Kovalčík, age 19, innovated a cheaper, faster way to produce an antiviral drug. Galidesivir targets RNA viruses like COVID-19, Ebola, and Zika but hasn't completed clinical trials. Kovalčík won a ...
News Medical on MSN
Enamine contributes to the discovery of promising broad-spectrum coronavirus antiviral
Enamine, a leading chemistry and R&D services company, today announced that it was a key synthetic chemistry contributor to a first-of-its-kind, open-science approach that led to the development of a ...
There are only three antivirals authorized by the US Food and Drug Administration (FDA) for treating COVID-19. If the ...
SHELTON, CT / ACCESS Newswire / October 20, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the “Company”), announced that its clinical lead drug NV-387 has shown strong ...
SHELTON, CT / ACCESS Newswire / July 21, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.: NNVC) (the "Company"), and a clinical stage, leading global pioneer in the development of ...
Hosted on MSN
A 19-year-old won $100,000 for inventing a cheaper, faster way to make antiviral drugs out of corn husks
When Adam Kovalčík flew to Ohio for an international science competition, he did not expect to come home with $100,000. The 19-year-old from Dulovce, Slovakia won that sum on Friday, though, because ...
Every time Morgan publishes a story, you’ll get an alert straight to your inbox! Enter your email By clicking “Sign up”, you agree to receive emails from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback